WE ARE DEVELOPING A PLATFORM OF DRUG CANDIDATES THAT HAVE THE POTENTIAL TO IMPROVE PATIENT’S LIVES BY TARGETING THE UNDERLYING CAUSES OF VASCULAR AND MIXED DEMENTIA.